JMP reaffirmed a Market Outperform rating and price target for Evolent Health, Inc. on July 4, 2025.
1 report, 0 independent
Updated Jul 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
JMP reaffirmed a Market Outperform rating and price target for Evolent Health, Inc. on July 4, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
JMP
suite of computer programs for statistical analysis developed by JMP Statistical Discovery LLC
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet